Source:http://linkedlifedata.com/resource/pubmed/id/10877200
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-7-18
|
pubmed:abstractText |
The purpose of the study was to examine the relationship between the endothelin-1 (ET-1) concentration and the metabolic variables characteristic of the insulin resistance syndrome ([IRS] hyperinsulinemia, insulin resistance, hypertriglyceridemia, low high-density lipoprotein [HDL] cholesterol, visceral obesity, and glycemic abnormalities). The measurement of circulating ET-1 is a well-recognized marker of endothelial atherosclerotic and cardiovascular disease. Two hundred subjects were divided into 3 groups. Group 1 included 50 subjects with impaired glucose tolerance (IGT) or non-insulin-dependent diabetes mellitus (NIDDM) with IRS. Group 2 included 50 subjects with IGT or NIDDM without IRS. Group 3 included 100 normal subjects as controls. ET-1 levels were higher in group 1 versus groups 2 and 3 in women (11.2 +/- 0.7 v 7.9 +/- 0.5 and 6.6 +/- 0.4 pg/mL, P < .01) and men (10.1 +/- 0.6 v 6.5 +/- 0.8 and 7.2 +/- 0.3 pg/mL, P < .01). No differences were found between groups 2 and 3. With simple regression analysis, ET-1 levels significantly correlated with insulin, glycosylated hemoglobin, body weight, waist to hip ratio, and triglyceride values. However, with multiple regression analysis, only triglycerides (P < .009) and glycosylated hemoglobin (P < .001) remained independently correlated with ET-1. In conclusion, this cross-sectional study indicates that glycosylated hemoglobin and triglycerides are independently correlated with ET-1 levels in patients with IRS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0026-0495
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
748-52
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10877200-Blood Glucose,
pubmed-meshheading:10877200-Body Weight,
pubmed-meshheading:10877200-Cholesterol,
pubmed-meshheading:10877200-Diabetes Mellitus, Type 2,
pubmed-meshheading:10877200-Endothelin-1,
pubmed-meshheading:10877200-Female,
pubmed-meshheading:10877200-Glucose Tolerance Test,
pubmed-meshheading:10877200-Hemoglobin A, Glycosylated,
pubmed-meshheading:10877200-Humans,
pubmed-meshheading:10877200-Insulin Resistance,
pubmed-meshheading:10877200-Male,
pubmed-meshheading:10877200-Middle Aged,
pubmed-meshheading:10877200-Regression Analysis,
pubmed-meshheading:10877200-Triglycerides
|
pubmed:year |
2000
|
pubmed:articleTitle |
Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome.
|
pubmed:affiliation |
Divisione di Medicina, Cattedra di Clinica Medica Generale e Terapia Medica, University of Milano, Istituto di Ricerca e Cura a Carrattere Scientifico H. San Raffaele, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|